In our study, the administration of cinacalcet to dialysis patients with CKD andsevere SHPT was safe and effective, and led to gradual sustained significantdecreases in the mean levels of PTH, calcium, and ALP throughout the 12 months forwhich the patients were followed. The gene discussed is PTH; the disease is chronic kidney disease.